Article: Algos Therapeutics Changes Name and Identity.

CRO to focus on preclinical pain research

ST. PAUL, Minn., and MINNEAPOLIS, Aug. 18 /PRNewswire/ -- Following a shift in its business model from developing proprietary pain therapy products to pure contract research, Algos Therapeutics has changed its name to Algos Preclinical Services. The company's new tagline, "Expertise in pain. Legendary service. Definitive results. For better quality of life." reinforces its repositioning as the go-to-CRO (Contract Research Organization) for drug discovery and product development.

Serving customers from Big Pharma to the biotech sectors, Algos Preclinical Services provides a wide range of services for companies ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!